Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
42.67
+0.53 (1.26%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $65 | Buy | Maintains | $65 | +52.33% | Aug 4, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $66 | Buy | Reiterates | $66 | +54.68% | Jul 27, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $63 | Buy | Maintains | $63 | +47.64% | Jul 13, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $65 | Buy | Maintains | $65 | +52.33% | Jul 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $63 → $67 | Buy | Maintains | $63 → $67 | +57.02% | Jul 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $55 | Hold | Maintains | $55 | +28.90% | May 6, 2026 |